miR-100-3p represses tumor growth by targeting BMPR2, whereas miR-100-5p inhibits cell growth by targeting CXCR7, represses invasion and metastasis by targeting ZBTB7A (Shi et al., 2015), and activates the autophagic pathway by targeting mTOR (Cao et al., 2018; Chen et al., 2018b; Peng et al., 2019). This evidence concerns the gene MTOR and neoplasm.